Innovations in NK Cell Engineering: How CAR-NK and iPSC-Derived Therapies Are Redefining Oncology and Autoimmunity
The therapeutic efficacy of Natural Killer (NK) cells is being dramatically amplified by continuous, cutting-edge innovations in cell engineering. The early phase of NK cell therapy relied on native, unmodified cells, but the current stage is defined by sophisticated genetic modification. Two innovations, in particular, are redefining the market's potential: Chimeric Antigen Receptor (CAR) NK...
0 Comments 0 Shares 18 Views 0 Reviews
Sponsored